4//SEC Filing
Astle Christopher 4
Accession 0000950170-23-069496
CIK 0001937653other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 8:00 PM ET
Size
9.4 KB
Accession
0000950170-23-069496
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Astle Christopher
SVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-11+1,550→ 2,883 total - Exercise/Conversion
Restricted Stock Unit
2023-12-11−1,550→ 0 total→ Common Stock (1,550 underlying) - Sale
Common Stock
2023-12-11$9.13/sh−886$8,089→ 1,997 total
Footnotes (5)
- [F1]Represents shares of common stock issued upon vesting of one half of the restricted stock units ("RSUs") granted on December 10, 2021.
- [F2]Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.11 to $9.16, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F4]Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F5]The RSUs were granted on December 10, 2021 and vested in two equal annual instalments (on December 12, 2022 and December 11, 2023).
Documents
Issuer
Zymeworks Inc.
CIK 0001937653
Entity typeother
Related Parties
1- filerCIK 0001915257
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 8:00 PM ET
- Size
- 9.4 KB